November, 2022

article thumbnail

The Bug Name Emoji Game

IDStewardship

On this webpage you will find “The Bug Name Emoji Game” which is just like “ The Drug Name Emoji Game ” and meant to be a fun medical emoji puzzle game for people who deal with different types of microbial pathogens.

334
334
article thumbnail

5 enduring mysteries of the Barry and Honey Sherman murders

PharmaVoice

After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators

144
144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Could digital therapeutics provide a solution against opioid abuse?

Pharma Phorum

Digital therapeutics are rapidly coming into the foreground to treat a variety of conditions. Ben Hargreaves discovers how chronic pain could be a key area for digital therapeutics, as they offer non-addictive and effective relief from the condition.

Dosage 135
article thumbnail

Higher Incidence of Myocarditis, Pericarditis Found After COVID-19 Vaccination

Pharmacy Times

Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

A Culture of Quality: The Catalyst to Accelerate Innovation

PharmExec

Why enabling a shared culture of quality across an organization is key to maintaining pharma’s recent pace of innovation wins—while inspiring new levels of confidence.

122
122
article thumbnail

More vaccinated than unvaccinated died from COVID-19 in August: analysis

Fierce Healthcare

More vaccinated than unvaccinated died from COVID-19 in August: analysis. fdiamond. Mon, 11/28/2022 - 16:34

Vaccines 145

More Trending

article thumbnail

The next era of Greater Boston’s biotech boom

PharmaVoice

How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth

126
126
article thumbnail

Advanced therapies and the high-profile pricing dilemma

Pharma Phorum

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations.

131
131
article thumbnail

Expert: Deprescribing Is an Important Part of End-of-Life Care

Pharmacy Times

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

181
181
article thumbnail

Digital Biomarkers Could Reshape CNS Diagnosis, Treatment

PharmExec

AI drives new signal-detection efforts in Alzheimer’s and ALS.

122
122
article thumbnail

From finding the right candidates to keeping them, how hospitals are using AI to address workforce needs

Fierce Healthcare

From finding the right candidates to keeping them, how hospitals are using AI to address workforce needs. aburky. Fri, 11/18/2022 - 15:25

Hospitals 144
article thumbnail

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments

Fierce Pharma

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. Thu, 11/10/2022 - 09:02

Vaccines 145
article thumbnail

The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

PharmaVoice

Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier

119
119
article thumbnail

Data privacy concerns don’t hinder digital health app usage

Pharma Phorum

A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on digital privacy differs widely among US users.

HIPAA 130
article thumbnail

Proof-of-Concept Study Shows Positive Results for Novel HIV Treatment

Pharmacy Times

Investigational broadly neutralizing antibody shows promise as potential as a first-in-class treatment option for HIV.

171
171
article thumbnail

How Clinical Trials Can Thrive in the Digital Era

PharmExec

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

104
104
article thumbnail

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

In a field dominated by antibodies and small molecules, two cell-therapy based approaches have come under the spotlight for showing early signs of efficacy in treating lupus.

article thumbnail

Moderna can't hide behind the government in patent infringement suit, judge rules

Fierce Pharma

Moderna can't hide behind the government in patent infringement suit, judge rules. zbecker. Thu, 11/03/2022 - 15:47

145
145
article thumbnail

4 pioneering social media campaigns in pharma this year

PharmaVoice

The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate

111
111
article thumbnail

First human trials of lab-grown red blood cells start in UK

Pharma Phorum

Blood cells grown in a laboratory have been given to people for the first time in a clinical trial being carried out by researchers in the UK, in the hope that plentiful supplies of rare blood groups can be manufactured to order.

126
126
article thumbnail

Dental Health Plays Vital Role in Cardiovascular Well-Being

Pharmacy Times

Research also focuses on connection between oral hygiene and other chronic diseases, neurological disorders, pulmonary infections.

162
162
article thumbnail

More than 300K healthcare providers dropped out of the workforce in 2021, report finds

Fierce Healthcare

More than 300K healthcare providers dropped out of the workforce in 2021, report finds. hlandi. Tue, 11/01/2022 - 10:57

144
144
article thumbnail

Exploring the “Other” End-User – HCPs and the Challenges to Adoption of Machine Learning-based Digital Solutions

PharmExec

Webinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST. us

98
article thumbnail

Dr Frank Mathias

Pharmafile

Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his new role in March 2023, when he will replace Dr Roch Doliveux. The firm focuses on cell and gene therapies.

95
article thumbnail

How bacteria-enabled technology for wounds could also help cancer patients

PharmaVoice

Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing

105
105
article thumbnail

Novartis said to be eyeing sale of ophthalmology, respiratory units

Pharma Phorum

Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports.

124
124
article thumbnail

Educating Patients with Chronic Kidney Disease Can Reduce Mortality Risk

Pharmacy Times

Active patient care with chronic kidney disease may provide enormous benefits for patients, the economy, and society.

article thumbnail

Amazon's latest push into digital health—a virtual clinic for common conditions like allergies and hair loss

Fierce Healthcare

Amazon's latest push into digital health—a virtual clinic for common conditions like allergies and hair loss. hlandi. Tue, 11/15/2022 - 09:18

140
140
article thumbnail

Tuning Into CTV - Real Time Data For Marketers

PharmExec

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.

98
article thumbnail

MHRA approves first gene therapy for infusion into the brain

European Pharmaceutical Review

Upstaza (eladocagene exuparvovec) is the first and only approved treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and is the first marketed gene therapy for direct infusion into the brain.

125
125
article thumbnail

In cancers with very low survival rates, Sellas aims higher

PharmaVoice

The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer

105
105
article thumbnail

Artificial Intelligence for better antibody drugs: ready for prime time?

Pharma Phorum

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were mAbs and this trend is forecasted to remain the same over the next five years.

123
123
article thumbnail

Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes Diagnostic

Pharmacy Times

When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.

160
160
article thumbnail

In face of 'tripledemic,' masking mandates might make a comeback

Fierce Healthcare

In face of 'tripledemic,' masking mandates might make a comeback. fdiamond. Mon, 11/28/2022 - 14:46

136
136
article thumbnail

Bottom of the Funnel Conversion though EHR Marketing and its Role in an Omnichannel Strategy

PharmExec

Webinar Date/Time: Wed, Dec 7, 2022 2:00 PM EST. us

97
article thumbnail

FDA approves first gene therapy for Haemophilia B

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes.